Raymond Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Raymond Li has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Ronald Lynel Castelino
School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
6 shared publications - Syed Tabish Razi Zaidi
School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS 7005, Australia
6 shared publications - Connie Van
School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia
5 shared publications - Kate Curtis
Faculty of Medicine and Health The University of Sydney Susan Wakil School of Nursing and Midwifery Camperdown New South Wales Australia
4 shared publications Amy Thomson
NSW Poisons Information Centre, Sydney Children’s Hospital Network, Camperdown, NSW, Australia
1 shared publication- Chin Yen Yeo
Western Sydney Local Health District, Blacktown and Mt Druitt Hospital, Mt Druitt, Australia
1 shared publication
Latest Publications
- Open Access
- 23 August 2026
- Published by Wiley in Journal of Clinical Nursing
Beyond Knowledge Transfer: Caregivers’ Evolving Medication Information Needs Across Paediatric Oncology Treatment
Aim: To identify and describe the medication information needs and preferences of caregivers of children with cancer, and the factors that support or impede those needs being met. Design: Qualitative descriptive study guided by reflexive thematic analysis. Methods: Between November 2024 and July 2025, semi‐structured interviews were conducted with 13 caregivers purposively recruited from a tertiary paediatric oncology centre in Australia. Data collection and analysis proceeded concurrently using reflexive thematic analysis. Results: Caregivers described receiving supportive medication information, yet their information needs persisted as responsibility for medication management shifted to families. Needs reflected the practical, emotional, and cognitive demands of translating clinical instructions into safe home‐based care. Caregivers relied on visual tools, written schedules, and trusted clinicians to support medication management. High satisfaction with medication information coexisted with vigilance and uncertainty, highlighting a gap between information provision and the realities of home‐based medication management. Conclusion: Medication information needs in paediatric oncology are dynamic and linked to the transfer of responsibility to families. Phased, system‐integrated approaches that support caregivers during care transitions and treatment are required. Implications for the Profession and Patient Care: Reconceptualising medication information as an iterative process rather than a discrete event is recommended. Transition support, decision aids, and standardised visual medication tools may reduce cognitive burden and enhance medication safety. Impact: This study addresses the gap between providing medication information and how caregivers manage complex home‐based regimens. Unmet needs stem from the demands of medication administration during care transitions and when managing ‘as required’ medicines. Findings offer practical insights for paediatric oncology nurses, pharmacists, and policymakers designing transition processes and medication safety strategies in family‐managed cancer care. Reporting Method: Consolidated Criteria for Reporting Qualitative Research 32‐item checklist. Public Contribution: Caregivers reviewed the interview guide prior to interviews and were invited to provide feedback; no changes were required.
- 23 August 2026
- Published by Wiley in Journal of Clinical Nursing
Open AccessBeyond Knowledge Transfer: Caregivers’ Evolving Medication Information Needs Across Paediatric Oncology Treatment
Aim: To identify and describe the medication information needs and preferences of caregivers of children with cancer, and the factors that support or impede those needs being met. Design: Qualitative descriptive study guided by reflexive thematic analysis. Methods: Between November 2024 and July 2025, semi‐structured interviews were conducted with 13 caregivers purposively recruited from a tertiary paediatric oncology centre in Australia. Data collection and analysis proceeded concurrently using reflexive thematic analysis. Results: Caregivers described receiving supportive medication information, yet their information needs persisted as responsibility for medication management shifted to families. Needs reflected the practical, emotional, and cognitive demands of translating clinical instructions into safe home‐based care. Caregivers relied on visual tools, written schedules, and trusted clinicians to support medication management. High satisfaction with medication information coexisted with vigilance and uncertainty, highlighting a gap between information provision and the realities of home‐based medication management. Conclusion: Medication information needs in paediatric oncology are dynamic and linked to the transfer of responsibility to families. Phased, system‐integrated approaches that support caregivers during care transitions and treatment are required. Implications for the Profession and Patient Care: Reconceptualising medication information as an iterative process rather than a discrete event is recommended. Transition support, decision aids, and standardised visual medication tools may reduce cognitive burden and enhance medication safety. Impact: This study addresses the gap between providing medication information and how caregivers manage complex home‐based regimens. Unmet needs stem from the demands of medication administration during care transitions and when managing ‘as required’ medicines. Findings offer practical insights for paediatric oncology nurses, pharmacists, and policymakers designing transition processes and medication safety strategies in family‐managed cancer care. Reporting Method: Consolidated Criteria for Reporting Qualitative Research 32‐item checklist. Public Contribution: Caregivers reviewed the interview guide prior to interviews and were invited to provide feedback; no changes were required.
- 1 September 2022
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 21 (9) , 1193-1204
A new paradigm in adverse drug reaction reporting: consolidating the evidence for an intervention to improve reporting
Adverse drug reaction (ADR) under-reporting is highly prevalent internationally and interventions created to address this problem have only been temporarily successful. This review aims to investig...
- 1 September 2022
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 21 (9) , 1193-1204
A new paradigm in adverse drug reaction reporting: consolidating the evidence for an intervention to improve reporting
Adverse drug reaction (ADR) under-reporting is highly prevalent internationally and interventions created to address this problem have only been temporarily successful. This review aims to investig...
- Open Access
- 27 April 2022
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 78 (7) , 1165-1175
Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework
Purpose: Adverse drug reaction (ADR) underreporting is highly prevalent across the world. This study aimed to identify factors associated with ADR reporting and map these to a behavioural change framework to help inform future interventions designed to improve ADR underreporting. Methods: A mixed methods survey was distributed to healthcare professionals at a tertiary hospital in Sydney, Australia. Quantitative data was analysed using logistic regression to identify factors that predict ADR reporting. Qualitative data was evaluated using content analysis. These were then integrated and mapped to the 14 domains within the Theoretical Domains Framework (TDF) to identify target areas relevant for improving ADR reporting. Results: One hundred thirty-three healthcare professionals completed the survey. Knowing how to report ADRs (OR 4.56, 95%CI 1.95–10.7), having been trained on ADR reporting (OR 2.72, 95%CI 1.29–5.77), and encountering ADRs as part of clinical practice (OR 10.3, 95%CI 3.59–29.4) were significant predictors of reporting an ADR. Content analysis identified three categories: modifying the ADR reporting process, enabling clinicians to report ADRs, and creating a positive ADR reporting culture. After data integration, the three target TDF domains were knowledge, environmental context/resources, and beliefs about consequences. Conclusion: Future interventions designed to improve ADR reporting should address these target domains to instigate behaviour change in healthcare professionals’ reporting of ADRs.
- 27 April 2022
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 78 (7) , 1165-1175
Open AccessWhy hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework
Purpose: Adverse drug reaction (ADR) underreporting is highly prevalent across the world. This study aimed to identify factors associated with ADR reporting and map these to a behavioural change framework to help inform future interventions designed to improve ADR underreporting. Methods: A mixed methods survey was distributed to healthcare professionals at a tertiary hospital in Sydney, Australia. Quantitative data was analysed using logistic regression to identify factors that predict ADR reporting. Qualitative data was evaluated using content analysis. These were then integrated and mapped to the 14 domains within the Theoretical Domains Framework (TDF) to identify target areas relevant for improving ADR reporting. Results: One hundred thirty-three healthcare professionals completed the survey. Knowing how to report ADRs (OR 4.56, 95%CI 1.95–10.7), having been trained on ADR reporting (OR 2.72, 95%CI 1.29–5.77), and encountering ADRs as part of clinical practice (OR 10.3, 95%CI 3.59–29.4) were significant predictors of reporting an ADR. Content analysis identified three categories: modifying the ADR reporting process, enabling clinicians to report ADRs, and creating a positive ADR reporting culture. After data integration, the three target TDF domains were knowledge, environmental context/resources, and beliefs about consequences. Conclusion: Future interventions designed to improve ADR reporting should address these target domains to instigate behaviour change in healthcare professionals’ reporting of ADRs.
- 9 June 2021
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 20 (10) , 1267-1274
Prevalence, characteristics, and reporting of adverse drug reactions in an Australian hospital: a retrospective review of hospital admissions due to adverse drug reactions
Background: Adverse drug reaction (ADR) related hospitalisations is a major cause of morbidity and mortality in Australia. This study investigated the prevalence, characteristics and reporting of ADR related hospitalisations at a tertiary hospital in Australia. Research design and methods: A retrospective review of all ADR related hospitalisations from October to December 2019 was conducted using eMedical Records. They were classified by medicine class, ADR type, preventability, and the strength of causal relationship. ADRs were searched within the regulator’s safety database to verify whether it was reported. Results: A total of 496 ADR related hospitalisations were identified from 5521 records (9.0%). Nervous system agents (32.3%) were responsible for most ADR hospitalisations and were more likely to cause psychiatric disorders (RR 9.71, 95%CI 4.98-18.87) than other types of ADRs. They were also more likely to cause preventable ADRs (HR 1.62, 95%CI 1.46-1.81). Patient age (OR 1.04, 95%CI 1.03-1.05) and the number of medicines (OR 1.13, 95%CI 1.11-1.15) were significantly associated with ADR related hospitalisations. Under-reporting to the national regulator was over 99%. Conclusions: ADR under-reporting is highly prevalent in Australian hospitals. Further research into identifying specific barriers towards reporting ADRs are needed to inform strategies with a focus on healthcare professionals involved in prescribing, dispensing and administrating nervous system agents.
- 9 June 2021
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 20 (10) , 1267-1274
Prevalence, characteristics, and reporting of adverse drug reactions in an Australian hospital: a retrospective review of hospital admissions due to adverse drug reactions
Background: Adverse drug reaction (ADR) related hospitalisations is a major cause of morbidity and mortality in Australia. This study investigated the prevalence, characteristics and reporting of ADR related hospitalisations at a tertiary hospital in Australia. Research design and methods: A retrospective review of all ADR related hospitalisations from October to December 2019 was conducted using eMedical Records. They were classified by medicine class, ADR type, preventability, and the strength of causal relationship. ADRs were searched within the regulator’s safety database to verify whether it was reported. Results: A total of 496 ADR related hospitalisations were identified from 5521 records (9.0%). Nervous system agents (32.3%) were responsible for most ADR hospitalisations and were more likely to cause psychiatric disorders (RR 9.71, 95%CI 4.98-18.87) than other types of ADRs. They were also more likely to cause preventable ADRs (HR 1.62, 95%CI 1.46-1.81). Patient age (OR 1.04, 95%CI 1.03-1.05) and the number of medicines (OR 1.13, 95%CI 1.11-1.15) were significantly associated with ADR related hospitalisations. Under-reporting to the national regulator was over 99%. Conclusions: ADR under-reporting is highly prevalent in Australian hospitals. Further research into identifying specific barriers towards reporting ADRs are needed to inform strategies with a focus on healthcare professionals involved in prescribing, dispensing and administrating nervous system agents.
- 31 March 2020
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 19 (6) , 747-753
Effect of the black triangle scheme and its online educational campaign on the quantity and quality of adverse drug event reporting in Australia: a time series analysis
The black triangle scheme was introduced to Australia in January 2018 to improve the significant under-reporting of adverse drug events (ADEs). The authors investigated the impact of the black tria...
- 31 March 2020
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 19 (6) , 747-753
Effect of the black triangle scheme and its online educational campaign on the quantity and quality of adverse drug event reporting in Australia: a time series analysis
The black triangle scheme was introduced to Australia in January 2018 to improve the significant under-reporting of adverse drug events (ADEs). The authors investigated the impact of the black tria...
- 14 November 2019
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 29 (1) , 1-8
Effectiveness of interventions to improve adverse drug reaction reporting by healthcare professionals over the last decade: A systematic review
Background: Various strategies have been studied in the literature to address the significant underreporting of adverse drug reactions (ADRs) in healthcare systems worldwide.Objectives: We conducted a systematic review of the literature that assessed the impact of various strategies to improve ADR reporting published in the last decade and compared this with the strategies identified in a previous systematic review.Methods: MEDLINE and EMBASE databases were used to retrieve papers published from 01 July 2010 to 17 June 2019. We included papers in the English language that investigated the quantitative impact of strategies used to improve ADR reporting.Results: A total of 10,021 articles were retrieved using our search criteria, of which 13 met the inclusion criteria. Multifaceted strategies resulted in a point estimate increase in ADR reporting of 9.26‐fold (−2.21–17.11, 95% CI) versus 7.19‐fold (−5.29–32.68, 95% CI) for single interventions. Using electronic reporting tools was more commonly identified as an interventional strategy with a point estimate increase of 13.69‐fold (−5.29–32.68, 95%CI) versus 4.42‐fold (0.66–8.19, 95% CI) for traditional educational methods. The quality of the majority of publications included in this review was low.Conclusions: Developments in digital technology in the last decade has led to the increased use of electronic reporting tools to improve ADR reporting. Higher quality studies investigating the impact of these electronic methods are needed to fully explore its role in improving ADR reporting.
- 14 November 2019
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 29 (1) , 1-8
Effectiveness of interventions to improve adverse drug reaction reporting by healthcare professionals over the last decade: A systematic review
Background: Various strategies have been studied in the literature to address the significant underreporting of adverse drug reactions (ADRs) in healthcare systems worldwide.Objectives: We conducted a systematic review of the literature that assessed the impact of various strategies to improve ADR reporting published in the last decade and compared this with the strategies identified in a previous systematic review.Methods: MEDLINE and EMBASE databases were used to retrieve papers published from 01 July 2010 to 17 June 2019. We included papers in the English language that investigated the quantitative impact of strategies used to improve ADR reporting.Results: A total of 10,021 articles were retrieved using our search criteria, of which 13 met the inclusion criteria. Multifaceted strategies resulted in a point estimate increase in ADR reporting of 9.26‐fold (−2.21–17.11, 95% CI) versus 7.19‐fold (−5.29–32.68, 95% CI) for single interventions. Using electronic reporting tools was more commonly identified as an interventional strategy with a point estimate increase of 13.69‐fold (−5.29–32.68, 95%CI) versus 4.42‐fold (0.66–8.19, 95% CI) for traditional educational methods. The quality of the majority of publications included in this review was low.Conclusions: Developments in digital technology in the last decade has led to the increased use of electronic reporting tools to improve ADR reporting. Higher quality studies investigating the impact of these electronic methods are needed to fully explore its role in improving ADR reporting.
- Open Access
- 10 August 2018
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 40 (4) , 878-889
Community pharmacists’ knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey
Background Under-reporting of adverse drug reactions (ADRs) by healthcare professionals is prevalent worldwide. Community pharmacists are the most frequently visited healthcare professional and are well placed to document ADRs as a part of their routine practice. Objective To measure community pharmacists’ knowledge and perspectives towards ADR reporting and their reporting practices. Setting Community pharmacists in the New South Wales, Queensland, Victoria and Tasmania, Australia. Method A survey tool consisting of 28 items was developed, piloted and validated by a panel of expert reviewers. The final anonymised survey was distributed online to community pharmacists. Exploratory factor analysis and Cronbach’s alpha were used to measure the validity and reliability of the tool, respectively. Non-parametric statistical tests were used to analyse knowledge, perspectives and ADR reporting practices. Main outcome measures: Knowledge, perceived importance, enablers and barriers to reporting ADRs. Results The survey tool showed acceptable validity and reliability. A total of 232 respondents completed the survey. The median knowledge score was 5 out of 10 (interquartile range, 2). Less than a third of respondents (31.0%) reported sufficient knowledge and training on ADR reporting. Only 35.3% of pharmacists reported at least one ADR in the previous 12 months. Non-reporting pharmacists were more likely to report lack of time as a barrier (P < 0.001), conversely they were more likely to report if the practice was remunerated (P = 0.007). Conclusion Under-reporting of ADRs by community pharmacists is highly prevalent. Initiatives to educate and train them on ADR reporting and simplifying the reporting process may improve reporting practices.
- 10 August 2018
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 40 (4) , 878-889
Open AccessCommunity pharmacists’ knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey
Background Under-reporting of adverse drug reactions (ADRs) by healthcare professionals is prevalent worldwide. Community pharmacists are the most frequently visited healthcare professional and are well placed to document ADRs as a part of their routine practice. Objective To measure community pharmacists’ knowledge and perspectives towards ADR reporting and their reporting practices. Setting Community pharmacists in the New South Wales, Queensland, Victoria and Tasmania, Australia. Method A survey tool consisting of 28 items was developed, piloted and validated by a panel of expert reviewers. The final anonymised survey was distributed online to community pharmacists. Exploratory factor analysis and Cronbach’s alpha were used to measure the validity and reliability of the tool, respectively. Non-parametric statistical tests were used to analyse knowledge, perspectives and ADR reporting practices. Main outcome measures: Knowledge, perceived importance, enablers and barriers to reporting ADRs. Results The survey tool showed acceptable validity and reliability. A total of 232 respondents completed the survey. The median knowledge score was 5 out of 10 (interquartile range, 2). Less than a third of respondents (31.0%) reported sufficient knowledge and training on ADR reporting. Only 35.3% of pharmacists reported at least one ADR in the previous 12 months. Non-reporting pharmacists were more likely to report lack of time as a barrier (P < 0.001), conversely they were more likely to report if the practice was remunerated (P = 0.007). Conclusion Under-reporting of ADRs by community pharmacists is highly prevalent. Initiatives to educate and train them on ADR reporting and simplifying the reporting process may improve reporting practices.